{"id":17504,"date":"2026-01-11T22:42:25","date_gmt":"2026-01-11T13:42:25","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4554\/"},"modified":"2026-08-23T12:20:49","modified_gmt":"2026-08-23T03:20:49","slug":"company-4554","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4554\/","title":{"rendered":"FUJI PHARMA CO LTD"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4554","DATE":"2026-06-04","longName":"Fuji Pharma Co., Ltd.","company_name_ja":"\u5bcc\u58eb\u88fd\u85ac\u5de5\u696d(\u682a)","fullTimeEmployees":1760,"address":"","phone":"","website":"https:\/\/www.fujipharma.jp","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":2122,"financialCurrency":"","marketCap":55426,"fiftyTwoWeekLow":1283,"fiftyTwoWeekHigh":2559,"epsTrailingTwelveMonths":122.94,"epsForward":0,"bookValue":0,"totalRevenue":51677000000,"OperatingIncome":4994000000,"operatingMargins":9.6600000000000001,"NetIncome":3000000000,"profitMargins":5.8099999999999996,"ebitda":0,"trailingPE":21.460356000000001,"forwardPE":13.637530999999999,"priceToBook":1.0792111,"returnOnEquity":6.4000000000000004,"recommendationMean":2,"recommendationKey":"buy","targetMeanPrice":3000,"numberOfAnalystOpinions":2,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:29:19.682920\", \"ticker\": \"4554\", \"ticker_full\": \"4554.T\", \"company_name\": \"FUJI PHARMA CO LTD\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"2\", \"strong_buy\": 0, \"buy\": 2, \"hold\": 0, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 2, \"recommendation_key\": \"buy\", \"recommendation_mean\": 2.0}, \"target_prices\": {\"has_data\": true, \"current\": 1861.0, \"high\": 3700.0, \"low\": 2300.0, \"mean\": 3000.0, \"median\": 3000.0}, \"earnings_dates\": {\"has_data\": false}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 42.77, \"institution_pct\": 13.96, \"major_holders\": [{\"label\": \"\", \"value\": 42.77}, {\"label\": \"\", \"value\": 13.96}, {\"label\": \"\", \"value\": 24.4}, {\"label\": \"\", \"value\": 37.0}], \"institutional_holders\": [], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":2.25,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":23,"get_dividend_history_year2":45.5,"get_dividend_history_year3":42.5,"get_dividend_history_year4":37,"get_dividend_history_year5":35,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:36:10.581985\", \"ticker\": \"4554\", \"ticker_full\": \"4554.T\", \"company_name\": \"FUJI PHARMA CO LTD\", \"company_info\": {\"name_en\": \"FUJI PHARMA CO LTD\", \"long_name\": \"Fuji Pharma Co., Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/www.fujipharma.jp\", \"employees\": 1760, \"country\": \"Japan\", \"city\": \"Tokyo\", \"address\": \"5-7 Sanban-cho\", \"description\": \"Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 1848.0, \"deviation\": -0.05, \"trend\": \"down\"}, \"ma_25\": {\"ma_value\": 1862.48, \"deviation\": -0.83, \"trend\": \"down\"}, \"ma_75\": {\"ma_value\": 2043.41, \"deviation\": -9.61, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 2031.93, \"deviation\": -9.1, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 51677000000.0, \"revenue_fmt\": \"\u00a5517\u5104\", \"gross_profit\": 20763000000.0, \"gross_profit_fmt\": \"\u00a5208\u5104\", \"operating_income\": 4994000000.0, \"operating_income_fmt\": \"\u00a550\u5104\", \"ebit\": 4330000000.0, \"ebit_fmt\": \"\u00a543\u5104\", \"net_income\": 3000000000.0, \"net_income_fmt\": \"\u00a530\u5104\", \"eps\": 122.94, \"operating_margin\": 9.66, \"total_assets\": 93405000000.0, \"total_assets_fmt\": \"\u00a5934\u5104\", \"total_equity\": 46902000000.0, \"total_equity_fmt\": \"\u00a5469\u5104\", \"total_debt\": 30937000000.0, \"total_debt_fmt\": \"\u00a5309\u5104\", \"total_cash\": 7245000000.0, \"total_cash_fmt\": \"\u00a572\u5104\", \"equity_ratio\": 50.21, \"de_ratio\": 0.66, \"current_ratio\": 1.55, \"operating_cf\": 5801000000.0, \"operating_cf_fmt\": \"\u00a558\u5104\", \"investing_cf\": -4219000000.0, \"investing_cf_fmt\": \"-\u00a542\u5104\", \"financing_cf\": 954000000.0, \"financing_cf_fmt\": \"\u00a510\u5104\", \"free_cf\": 1947000000.0, \"free_cf_fmt\": \"\u00a519\u5104\", \"net_margin\": 5.81, \"roe\": 6.4, \"roa\": 3.21}, {\"year\": 2024, \"revenue\": 46138000000.0, \"revenue_fmt\": \"\u00a5461\u5104\", \"gross_profit\": 17844000000.0, \"gross_profit_fmt\": \"\u00a5178\u5104\", \"operating_income\": 3883000000.0, \"operating_income_fmt\": \"\u00a539\u5104\", \"ebit\": 8472000000.0, \"ebit_fmt\": \"\u00a585\u5104\", \"net_income\": 6146000000.0, \"net_income_fmt\": \"\u00a561\u5104\", \"eps\": 252.85, \"operating_margin\": 8.42, \"total_assets\": 90000000000.0, \"total_assets_fmt\": \"\u00a5900\u5104\", \"total_equity\": 45558000000.0, \"total_equity_fmt\": \"\u00a5456\u5104\", \"total_debt\": 29254000000.0, \"total_debt_fmt\": \"\u00a5293\u5104\", \"total_cash\": 4585000000.0, \"total_cash_fmt\": \"\u00a546\u5104\", \"equity_ratio\": 50.62, \"de_ratio\": 0.64, \"current_ratio\": 1.19, \"operating_cf\": 4151000000.0, \"operating_cf_fmt\": \"\u00a542\u5104\", \"investing_cf\": -1658000000.0, \"investing_cf_fmt\": \"-\u00a517\u5104\", \"financing_cf\": -435000000.0, \"financing_cf_fmt\": \"-\u00a54\u5104\", \"free_cf\": -221000000.0, \"free_cf_fmt\": \"-\u00a52\u5104\", \"net_margin\": 13.32, \"roe\": 13.49, \"roa\": 6.83}, {\"year\": 2023, \"revenue\": 40889000000.0, \"revenue_fmt\": \"\u00a5409\u5104\", \"gross_profit\": 16514000000.0, \"gross_profit_fmt\": \"\u00a5165\u5104\", \"operating_income\": 3862000000.0, \"operating_income_fmt\": \"\u00a539\u5104\", \"ebit\": 4506000000.0, \"ebit_fmt\": \"\u00a545\u5104\", \"net_income\": 3435000000.0, \"net_income_fmt\": \"\u00a534\u5104\", \"eps\": 141.37, \"operating_margin\": 9.45, \"total_assets\": 85332000000.0, \"total_assets_fmt\": \"\u00a5853\u5104\", \"total_equity\": 41172000000.0, \"total_equity_fmt\": \"\u00a5412\u5104\", \"total_debt\": 28948000000.0, \"total_debt_fmt\": \"\u00a5289\u5104\", \"total_cash\": 2324000000.0, \"total_cash_fmt\": \"\u00a523\u5104\", \"equity_ratio\": 48.25, \"de_ratio\": 0.7, \"current_ratio\": 1.31, \"operating_cf\": 1917000000.0, \"operating_cf_fmt\": \"\u00a519\u5104\", \"investing_cf\": -5240000000.0, \"investing_cf_fmt\": \"-\u00a552\u5104\", \"financing_cf\": 1915000000.0, \"financing_cf_fmt\": \"\u00a519\u5104\", \"free_cf\": -1980000000.0, \"free_cf_fmt\": \"-\u00a520\u5104\", \"net_margin\": 8.4, \"roe\": 8.34, \"roa\": 4.03}, {\"year\": 2022, \"revenue\": 35426000000.0, \"revenue_fmt\": \"\u00a5354\u5104\", \"gross_profit\": 14558000000.0, \"gross_profit_fmt\": \"\u00a5146\u5104\", \"operating_income\": 3781000000.0, \"operating_income_fmt\": \"\u00a538\u5104\", \"ebit\": 3800000000.0, \"ebit_fmt\": \"\u00a538\u5104\", \"net_income\": 2696000000.0, \"net_income_fmt\": \"\u00a527\u5104\", \"eps\": 111.01, \"operating_margin\": 10.67, \"total_assets\": 75538000000.0, \"total_assets_fmt\": \"\u00a5755\u5104\", \"total_equity\": 35801000000.0, \"total_equity_fmt\": \"\u00a5358\u5104\", \"total_debt\": 24569000000.0, \"total_debt_fmt\": \"\u00a5246\u5104\", \"total_cash\": 3546000000.0, \"total_cash_fmt\": \"\u00a535\u5104\", \"equity_ratio\": 47.39, \"de_ratio\": 0.69, \"current_ratio\": 1.45, \"operating_cf\": -658000000.0, \"operating_cf_fmt\": \"-\u00a57\u5104\", \"investing_cf\": -11271000000.0, \"investing_cf_fmt\": \"-\u00a5113\u5104\", \"financing_cf\": 5094000000.0, \"financing_cf_fmt\": \"\u00a551\u5104\", \"free_cf\": -13081000000.0, \"free_cf_fmt\": \"-\u00a5131\u5104\", \"net_margin\": 7.61, \"roe\": 7.53, \"roa\": 3.57}, {\"year\": 2021, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 35.0}, {\"year\": 2023, \"amount\": 37.0}, {\"year\": 2024, \"amount\": 42.5}, {\"year\": 2025, \"amount\": 45.5}, {\"year\": 2026, \"amount\": 23.0}], \"latest\": 23.0, \"has_data\": true}}","ma_5_value":2225.5999999999999,"ma_5_deviation":-4.6500000000000004,"ma_5_trend":"down","ma_25_value":2179.4000000000001,"ma_25_deviation":-2.6299999999999999,"ma_25_trend":"down","ma_75_value":2289.5700000000002,"ma_75_deviation":-7.3200000000000003,"ma_75_trend":"down","ma_200_value":1900.01,"ma_200_deviation":11.68,"ma_200_trend":"up","previousClose":2178,"open":2174,"dayHigh":2175,"dayLow":2114,"volume":13600,"averageVolume":138931,"revenueGrowth":0},"sector":[],"class_list":["post-17504","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FUJI PHARMA CO LTD - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4554\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4554\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4554\/\",\"name\":\"FUJI PHARMA CO LTD - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-01-11T13:42:25+00:00\",\"dateModified\":\"2026-08-23T03:20:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4554\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4554\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4554\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FUJI PHARMA CO LTD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FUJI PHARMA CO LTD - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4554\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4554\/","url":"https:\/\/japanir.jp\/en\/company\/company-4554\/","name":"FUJI PHARMA CO LTD - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-01-11T13:42:25+00:00","dateModified":"2026-08-23T03:20:49+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4554\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4554\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4554\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"FUJI PHARMA CO LTD"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/17504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=17504"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=17504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}